Hence, IL-33 signaling in ILC2s plays a critical role in the pathogenesis of IRI–induced renal fibrosis and treatment with IL-33 inhibitor reduced pro-inflammatory cytokine and chemokine levels in the kidneys of mice following IRI insult (54). Here, IL33 is linked to renal fibrosis.